Certain foods, nutrients, and supplements can help lower the risk of stroke. These include leafy greens, whole grains, folic ...

The estrogen deficit of perimenopause can also slow down your metabolism—an outcome of aging as well—and make you less ...

The hazard ratio (HR) for the primary endpoint was (3.84, p = 0.0009) in the first month The Prolocor pFCG™ test has the potential to help providers reduce 30-day readmission rates for Acute MI, an ...

DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia and acute ischemic stroke, announced today that its third quarter 2025 ...

Pat has a strong track record as a seasoned and strategic leader of medical technology companies, helping them catalyze new markets and scale internationally,” said Tony Chou, Chief Executive Officer ...

Patients who undergo general anesthesia while receiving a specialized surgery to treat strokes have better outcomes than ...

When Joseph Broderick was a college sophomore in 1975, stroke treatment was a waiting game. Doctors could diagnose a stroke but couldn’t stop it. There were no scientifically proven therapies, no ...

In a randomized trial, adding an antiplatelet to anticoagulant therapy in patients with ischemic stroke, nonvalvular atrial fibrillation, and atherosclerosis provided no significant benefit. There was ...

Functional recovery after EVT for AIS varies by race and ethnicity, even though procedural success is similar across groups.

Racial and ethnic disparities in United States stroke care vary by intervention type at the national and state levels.

Lumosa Therapeutics Co. Ltd.’s intravenous odatroltide (LT-3001) met the primary endpoints in a phase IIb trial in China in patients with acute ischemic stroke, paving the way for a pivotal phase III ...